Publicacions científiques

Editorial

To be it, you must see it: On increasing the visibility of women and other groups underrepresented in medicine.

Autor/s:

Hinson HE, Gonzales NR.

Editorial

Any publicació:

2020

Número de revista:

Neurology vol. 95 n. 22

https://n.neurology.org/content/95/22/991

Editorial

To predict recurrence in cerebral amyloid angiopathy, look to the subarachnoid space.

Autor/s:

Smith EE, Maas MB.

Editorial

Any publicació:

2020

Número de revista:

Neurology vol. 94 n. 9

https://n.neurology.org/content/94/9/375

Editorial

Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years.

Autor/s:

Cheng Y, Wang YJ.

Editorial

Any publicació:

2020

Número de revista:

Neurology vol. 94 n. 20

https://n.neurology.org/content/94/20/860

Article

Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.

Autor/s:

Mappin-Kasirer B, Pan H, Lewington S, Kizza J, Gray R, Clarke R, Peto R.

Any publicació:

2020

Número de revista:

Neurology vol. 94 n. 20

https://n.neurology.org/content/94/20/e2132

Article

Too harts, won sole: Using dysgraphia treatment to address homophone representation.

Autor/s:

Barr P, Biedermann B, Tainturier MJ, Kohnen S, Nickels L.

Any publicació:

2020

Número de revista:

Neuropsychological Rehabilitation vol. 30 n. 10

https://www.tandfonline.com/doi/full/10.1080/09602011.2019.1629302

Article

Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.

Autor/s:

Doecke JD, Pérez-Grijalba V, Fandos N, Fowler C, Villemagne VL, Masters CL, Pesini P, Sarasa M; AIBL Research Group.

Any publicació:

2020

Número de revista:

Neurology vol. 94 n. 15

https://n.neurology.org/content/94/15/e1580

Article

Toward Better Reporting Standards of Patients' Characteristics in Rehabilitation Trials: Applying a New Conceptual Framework to Current Standards.

Autor/s:

Meyer T, Selb M, Kiekens C, Grubišić F, Arienti C, Stucki G, Negrini S.

Any publicació:

2020

Número de revista:

American Journal of Physical Medicine & Rehabilitation. vol. 99 n. 3

https://journals.lww.com/ajpmr/Fulltext/2020/03000/Toward_Better_Reporting_Stand…

Editorial

Towards biomarker-based clinical subtyping of Parkinson's disease.

Autor/s:

Lamotte G, Becker B.

Editorial

Any publicació:

2020

Número de revista:

Neurology vol. 95 n. 11

https://n.neurology.org/content/95/11/461

Article

Trabajo social sanitario y COVID-19: la formación, base necesaria para una intervención profesional y científicamente fundamentada. Estudio realizado dentro de programa formativa Máster Universitario de Trabajo Social Sanitario de la UOC

Autor/s:

Rueda Estrada JD

Any publicació:

2020

Número de revista:

Agathos vol. 20 n. 2

http://www.revista-agathos.com/Publicados/2020/junio/junio.pdf

Editorial

Tracking therapies in MS: More evidence in favor of neurofilament.

Autor/s:

Yeh EA, Sormani MP.

Editorial

Any publicació:

2020

Número de revista:

Neurology vol. 94 n. 11

https://n.neurology.org/content/94/11/465

Una iniciativa de:

Cercador

To be it, you must see it: On increasing the visibility of women and other groups underrepresented in medicine.

To predict recurrence in cerebral amyloid angiopathy, look to the subarachnoid space.

Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years.

Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.

Too harts, won sole: Using dysgraphia treatment to address homophone representation.

Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.

Toward Better Reporting Standards of Patients' Characteristics in Rehabilitation Trials: Applying a New Conceptual Framework to Current Standards.

Towards biomarker-based clinical subtyping of Parkinson's disease.

Trabajo social sanitario y COVID-19: la formación, base necesaria para una intervención profesional y científicamente fundamentada. Estudio realizado dentro de programa formativa Máster Universitario de Trabajo Social Sanitario de la UOC

Tracking therapies in MS: More evidence in favor of neurofilament.

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!